Joachim Struck

Heart Failure & Transplant

Inserm

About

Joachim Struck works in Heart Failure & Transplant affiliated with Inserm.

Joachim Struck is the co-founder and Head of R&D at AdrenoMed AG in Hennigsdorf, Germany. He previously developed immunoassays at BRAHMS AG and conducted biomarker research at Sphingotec GmbH. His research includes stable peptides for diagnosing and managing cardiovascular diseases such as heart failure and myocardial infarction.

Research focus

Biomarker development for heart failure prognosisCopeptin assays for acute myocardial infarctionPro-adrenomedullin in cardiovascular risk assessmentNatriuretic peptides in blood pressure and heart diseaseProcalcitonin as prognostic marker in cardiac conditions

Impact

296 pubs · 16,461 cites · h-index 73

Training

PhD
Free University Berlin
Postdoctoral fellowship
University of Massachusetts Amherst

Affiliations

Work Experience

AdrenoMed AG

2013 - Present

Sphingotec GmbH